HairDx Opens European Subsidiary | GenomeWeb

NEW YORK (GenomeWeb News) – Molecular dermatology company HairDx, a subsidiary of PharmaGenoma, has launched a Belgian subsidiary to market its hair loss predictive test products in Europe, the company said today.

PharmaGenoma said that the HairDx Europe subsidiary will offer throughout Europe its genetic test for Androgenetic Alopecia, which the company said is the most common cause of hair loss in both men and women. The company noted that it has recently struck distribution agreements for the HairDX test in Italy and Japan.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.